½ÃÀ庸°í¼­
»óǰÄÚµå
1781133

¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)

Cell Harvesting System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Persistence Market Research´Â ¼¼°è ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Á¶»ç º¸°í¼­¸¦ ¹ßÇ¥ÇßÀ¸¸ç, ¿øµ¿·Â, »õ·Î¿î µ¿Çâ, ±âȸ, °úÁ¦ µî ÁÖ¿ä ½ÃÀå ¿ªÇп¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇß½À´Ï´Ù. º» º¸°í¼­´Â ½ÃÀå »óȲÀ» »ó¼¼È÷ ÆÄ¾ÇÇÏ¿© ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

  • ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð(2025³â) : 69¾ï ´Þ·¯
  • ¿¹Ãø ½ÃÀå °¡Ä¡(2032³â) : 155¾ï ´Þ·¯
  • ¼¼°è ½ÃÀå ¼ºÀå·ü(2025-2032³â CAGR) : 12.2%

¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå - º¸°í¼­ ¹üÀ§:

¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå¿¡´Â ¿¬±¸, Ä¡·á, Áø´Ü ¸ñÀûÀ¸·Î ¼¼Æ÷¸¦ äÃë, ºÐ¸®, ³óÃàÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àåºñ¿Í ±â¼úÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¼¼Æ÷ Ä¡·á, Àç»ýÀÇ·á, ¹ÙÀÌ¿ÀÀǾàǰ Á¦Á¶, Àӻ󿬱¸¿¡ ÇʼöÀûÀÔ´Ï´Ù. Á¤¹ÐÀÇ·á ¹× ¸ÂÃãÄ¡·á¿¡ ´ëÇÑ ¼¼°è ¼ö¿ä Áõ°¡¿Í ¼¼Æ÷ ±â¹Ý ¿¬±¸ ¹× Àç»ý ¾ÖÇø®ÄÉÀ̼ÇÀÇ ±Þ°ÝÇÑ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È »ó´çÇÑ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

Áٱ⼼Æ÷ ¹× ¸é¿ª¿ä¹ýÀ» Æ÷ÇÔÇÑ ¼¼Æ÷ ±â¹Ý Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ¾Ï, ÀÚ°¡¸é¿ªÁúȯ µî ¸¸¼ºÁúȯ ¹× ÅðÇ༺ ÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ÷´Ü »ýÀÇÇÐ ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ°¡ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, È¿À²ÀûÀÎ ¼¼Æ÷ äÃë µµ±¸ÀÇ Çʿ伺ÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À Á¦¾à »ê¾÷ÀÇ È®´ë¿Í Çмú ¹× ÀÓ»ó ¿¬±¸ ±â°ü¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÚµ¿È­ ¹× È®Àå °¡´ÉÇÑ ¼¼Æ÷ äÃë ±â¼úÀÇ ¹ßÀüÀº ´õ ³ôÀº ¼öÀ²°ú ´õ ³ªÀº ǰÁúÀÇ ¼¼Æ÷ »ùÇÃÀ» °¡´ÉÇÏ°Ô ÇÏ¿© Àü ¼¼°è ½ÃÀå µµÀÔÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¾ïÁ¦¿äÀÎ:

°­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµÇ´Â ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀåÀº ÀÏÁ¤ÇÑ Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. ƯÈ÷ Áß¼Ò±Ô¸ðÀÇ ¿¬±¸½Ã¼³ÀÇ °æ¿ì, ÀÚµ¿È­ ½Ã½ºÅÛ ¹× À¯Áöº¸¼ö¿Í °ü·ÃµÈ ³ôÀº ÀÚº»ºñ¿ëÀÌ Å« À庮ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÓ»ó Àû¿ëÀÇ °æ¿ì, ±ÔÁ¦ À庮°ú ¾ö°ÝÇÑ ÄÄÇöóÀ̾𽺠¿ä°ÇÀÌ Á¦Ç° °³¹ß ¹× »ó¿ëÈ­¸¦ Áö¿¬½Ãų ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ äÃë ÀýÂ÷¿¡¼­ ¼¼Æ÷ÀÇ »ýÁ¸¼º°ú ¼øµµ À¯Áö¿¡ ´ëÇÑ ±â¼úÀû °úÁ¦´Â º¸±ÞÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ ÀηÂÀÌ ºÎÁ·Çϰí Á¶ÀÛÀÌ º¹ÀâÇÏ´Ù´Â Á¡µµ °³¹ßµµ»ó±¹¿¡¼­ÀÇ º¸±ÞÀ» ´ÊÃß´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

Àç»ýÀÇ·á¿Í ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå¿¡ dzºÎÇÑ ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï±¹µéÀº ÇコÄɾî ÀÎÇÁ¶ó¿Í ¹ÙÀÌ¿ÀÀǾàǰ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖÀ¸¸ç, ½ÃÀå ħÅõ¸¦ À§ÇÑ »õ·Î¿î ±æÀ» °³Ã´Çϰí ÀÖ½À´Ï´Ù. ÀÏȸ¿ë ±â¼ú°ú ¹Ì¼¼À¯Ã¼ °øÇÐÀÇ ²÷ÀÓ¾ø´Â Çõ½ÅÀº ¼¼Æ÷ äÃë °úÁ¤À» °£¼ÒÈ­ÇÏ°í ¿À¿° À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÁ¦¾à±â¾÷°ú Çмú±â°üÀÇ °øµ¿ ¿¬±¸´Â ÇÏÀ̽º·çDz ½Ã½ºÅÛ °³¹ßÀ» ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ, GMP(Good Manufacturing Practice) ȯ°æ¿¡ ¸Â°Ô Á¶Á¤µÈ ÀÚµ¿È­µÈ Æó¼âÇü ½Ã½ºÅÛ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ½ÃÀå °ü°èÀڵ鿡°Ô Å« ¼ºÀå ÀáÀç·ÂÀ» º¸¿©ÁÖ°í ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®

  • ¼¼°è ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • ¼¼Æ÷ äÃë ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä°¡ °¡Àå ³ôÀº Áö¿ª°ú ½ÃÀå ºÎ¹®Àº ¾îµðÀΰ¡?
  • ÀÚµ¿È­ ¹× ¹ÙÀÌ¿ÀÇÁ·Î¼¼½ºÀÇ ±â¼ú ¹ßÀüÀº ½ÃÀå¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?
  • ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä Ç÷¹À̾î´Â ´©±¸À̸ç, °æÀï·ÂÀ» À¯ÁöÇϱâ À§ÇØ ¾î¶² Àü·«À» äÅÃÇϰí Àִ°¡?
  • ¼¼°è ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀåÀÇ »õ·Î¿î Æ®·»µå¿Í ÇâÈÄ Àü¸ÁÀº?

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå °³¿ä

  • ½ÃÀå ¹üÀ§¿Í Á¤ÀÇ
  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • ÁÖ¿ä µ¿Çâ
  • °Å½Ã°æÁ¦ ¿äÀÎ
    • ¼¼°èÀÇ ºÎ¹®º° Àü¸Á
    • ¼¼°è GDP ¼ºÀå Àü¸Á
  • COVID-19ÀÇ ¿µÇ⠺м®
  • ¿¹Ãø¿äÀÎ - °ü·Ã¼º°ú ¿µÇâ

Á¦3Àå ºÎ°¡°¡Ä¡ ÀÖ´Â ÀλçÀÌÆ®

  • Á¦Ç° ä¿ë ºÐ¼®
  • ±ÔÁ¦ »óȲ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä °Å·¡¿Í ÇÕº´
  • PESTLE ºÐ¼®
  • Porter's Five Forces ºÐ¼®

Á¦4Àå °¡°Ý ºÐ¼®, 2024A

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • Á¦Ç° °¡°Ý¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ¿äÀÎ
  • Á¦Ç°º° °¡°Ý ºÐ¼®
  • Áö¿ª °¡°Ý°ú Á¦Ç° ±âÈ£

Á¦5Àå ¼¼°èÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
    • ½ÃÀå ±Ô¸ð ¿¹Ãø
    • ½ÃÀå ±Ô¸ð¿Í Àü³âºñ ¼ºÀå·ü
    • Àý´ëÀû ¼öÀÍ ±âȸ
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø
    • 2019-2024³â ½ÃÀå ±Ô¸ðÀÇ ¿ª»çÀû ºÐ¼®
    • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
  • ¼¼°èÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á : Á¦Ç°
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð¡¤¼ö·® ºÐ¼®, 2019-2024³â
    • ½ÃÀå ±Ô¸ð¡¤¼ö·® ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
      • ¼öµ¿ ¼¼Æ÷ äÃë Àåºñ
      • ÀÚµ¿ ¼¼Æ÷ äÃë Àåºñ
    • ½ÃÀå ¸Å·Â ºÐ¼® : Á¦Ç°
  • ¼¼°èÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á : ¿ëµµ
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2024³â
    • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
      • ¹ÙÀÌ¿ÀÀǾàǰ ¿ëµµ
      • ¼¼Æ÷ Ä¡·á
      • Á¶Á÷°øÇÐ
      • ÀÓ»ó Á¶»ç¿Í ½ÃÇè
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµ
  • ¼¼°èÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á : ÃÖÁ¾»ç¿ëÀÚ
    • ¼Ò°³/ÁÖ¿ä Á¶»ç °á°ú
    • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2024³â
    • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
      • º´¿ø
      • ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ¹× ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
      • Áø´Ü ½ÇÇè½Ç
      • ÇмúÁ¶»ç±â°ü
      • ±âŸ
    • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚ

Á¦6Àå ¼¼°èÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á : Áö¿ª

  • ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
  • °ú°Å ½ÃÀå ±Ô¸ð ºÐ¼®, 2019-2024³â
  • ½ÃÀå ±Ô¸ð ºÐ¼®°ú ¿¹Ãø, 2025-2032³â
    • ºÏ¹Ì
    • À¯·´
    • µ¿¾Æ½Ã¾Æ
    • ³²¾Æ½Ã¾Æ¿Í ¿À¼¼¾Æ´Ï¾Æ
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ª

Á¦7Àå ºÏ¹ÌÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦8Àå À¯·´ÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦9Àå µ¿¾Æ½Ã¾ÆÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦10Àå ³²¾Æ½Ã¾Æ ¹× ¿À¼¼¾Æ´Ï¾ÆÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦11Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦12Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷ äÃë ½Ã½ºÅÛ ½ÃÀå Àü¸Á

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â
  • ½ÃÀå ±¸Á¶
    • ½ÃÀ庰 °æÀï °­µµ ¸ÅÇÎ
    • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Esco Micro Pte. Ltd.
    • Sartorius AG
    • Cytiva(Danaher)
    • Technical Proteins Nanobiotechnology
    • Beckman Coulter, Inc
    • Thermo Fisher Scientific Inc.
    • Dr. Mueller AG
    • Corning Incorporated
    • PerkinElmer
    • Revvity
    • Smart MCs PTY LTD
    • CARR Biosystems
    • ScaleReady USA
    • SINFONIA TECHNOLOGY CO., LTD
    • Cole-Parmer Instrument Company, LLC
    • Human Med
    • ADS Biotec Inc.
    • Akadeum Life Sciences
    • AVITA Medical
    • Tomtec

Á¦14Àå ºÎ·Ï

  • Á¶»ç ¹æ¹ý
  • Á¶»ç °¡Á¤
  • µÎ¹®ÀÚ¾î¿Í ¾à¾î
ksm 25.08.06

Persistence Market Research has recently released a comprehensive report on the global Cell Harvesting System Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

  • Cell Harvesting System Market Size (2025E): US$ 6.9 Bn
  • Projected Market Value (2032F): US$ 15.5 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 12.2%

Cell Harvesting System Market - Report Scope:

The cell harvesting system market encompasses a variety of devices and technologies used to collect, isolate, and concentrate cells for research, therapeutic, and diagnostic purposes. These systems are vital in cell therapy, regenerative medicine, biopharmaceutical manufacturing, and clinical research. The rising global demand for precision medicine and personalized therapeutics, along with the surge in cell-based research and regenerative applications, is driving significant market growth during the forecast period.

Market Growth Drivers:

The growing demand for cell-based therapies, including stem cell and immunotherapy treatments, is a major driver of the cell harvesting system market. Increasing prevalence of chronic and degenerative diseases, such as cancer and autoimmune disorders, has spurred investment in advanced biomedical research, boosting the need for efficient cell harvesting tools. The expansion of the biopharmaceutical industry and increasing funding in academic and clinical research institutions also support market growth. Moreover, advancements in automation and scalable harvesting technologies are enabling higher yield and better-quality cell samples, further propelling market adoption globally.

Market Restraints:

Despite strong growth prospects, the cell harvesting system market faces certain limitations. High capital costs associated with automated systems and maintenance can be a significant barrier, particularly for small and mid-sized research facilities. Regulatory hurdles and stringent compliance requirements, especially in clinical applications, may delay product development and commercialization. Furthermore, technical challenges in maintaining cell viability and purity during harvesting procedures can limit widespread adoption. Limited skilled personnel and operational complexities also contribute to slower uptake in developing regions.

Market Opportunities:

The increasing focus on regenerative medicine and personalized treatment approaches offers abundant opportunities for the cell harvesting system market. Emerging economies are investing in healthcare infrastructure and biopharma R&D, creating new avenues for market penetration. Continuous innovation in single-use technologies and microfluidics can streamline harvesting processes and reduce contamination risks. Collaborations between biopharma companies and academic institutions are likely to enhance the development of high-throughput systems. Moreover, growing demand for automated, closed-system solutions tailored for Good Manufacturing Practice (GMP) environments presents a substantial growth potential for market players.

Key Questions Answered in the Report:

  • What are the primary factors driving the global cell harvesting system market's growth?
  • Which regions and market segments are experiencing the highest demand for cell harvesting systems?
  • How are technological advancements in automation and bioprocessing impacting the market?
  • Who are the key players in the cell harvesting system market, and what strategies are they adopting to remain competitive?
  • What are the emerging trends and future projections for the global cell harvesting system market?

Competitive Intelligence and Business Strategy:

Leading companies in the global cell harvesting system market, such as Esco Micro Pte. Ltd., Sartorius AG, Cytiva (Danaher), Thermo Fisher Scientific Inc., and Beckman Coulter, Inc., are focusing on innovation, strategic collaborations, and capacity expansion to strengthen their market presence. These players are actively developing automated and closed-system harvesters that ensure reproducibility and compliance with regulatory standards. Investments in R&D, especially in scalable and GMP-compliant systems, are supporting their efforts to cater to biopharmaceutical and clinical research applications. Establishing a strong distribution network and customizing solutions for regional markets remain key components of their growth strategy.

Companies Covered in This Report:

  • Esco Micro Pte. Ltd.
  • Sartorius AG
  • Cytiva (Danaher)
  • Technical Proteins Nanobiotechnology
  • Beckman Coulter, Inc
  • Thermo Fisher Scientific Inc.
  • Dr. Mueller AG
  • Corning Incorporated
  • PerkinElmer
  • Revvity
  • Smart MCs PTY LTD
  • CARR Biosystems
  • ScaleReady USA
  • SINFONIA TECHNOLOGY CO., LTD.

Market Segmentation

By Product

  • Manual Cell Harvesters
  • Automated Cell Harvesters

By Application

  • Biopharmaceutical Applications
  • Cell Therapy
  • Tissue Engineering
  • Clinical Research & Trials
  • Others

By End-user

  • Hospitals
  • Biotech & Biopharma Companies
  • Academic & Research Institutes
  • Diagnostic Labs
  • Others

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Cell Harvesting System Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Price Analysis, 2024A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Cell Harvesting System Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 5.3. Global Cell Harvesting System Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Manual Cell Harvesters
      • 5.3.3.2. Automated Cell Harvesters
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Cell Harvesting System Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2024
    • 5.4.3. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Biopharmaceutical Applications
      • 5.4.3.2. Cell Therapy
      • 5.4.3.3. Tissue Engineering
      • 5.4.3.4. Clinical Research & Trials
      • 5.4.3.5. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Cell Harvesting System Market Outlook: End-user
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Bn) Analysis, By End-user, 2019-2024
    • 5.5.3. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
      • 5.5.3.1. Hospitals
      • 5.5.3.2. Biotech & Biopharma Companies
      • 5.5.3.3. Diagnostic Labs
      • 5.5.3.4. Academic & Research Institutes
      • 5.5.3.5. Others
    • 5.5.4. Market Attractiveness Analysis: End-user

6. Global Cell Harvesting System Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Cell Harvesting System Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By End-user
  • 7.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Manual Cell Harvesters
    • 7.4.2. Automated Cell Harvesters
  • 7.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Biopharmaceutical Applications
    • 7.5.2. Cell Therapy
    • 7.5.3. Tissue Engineering
    • 7.5.4. Clinical Research & Trials
    • 7.5.5. Others
  • 7.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Biotech & Biopharma Companies
    • 7.6.3. Diagnostic Labs
    • 7.6.4. Academic & Research Institutes
    • 7.6.5. Others
  • 7.7. Market Attractiveness Analysis

8. Europe Cell Harvesting System Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By End-user
  • 8.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Manual Cell Harvesters
    • 8.4.2. Automated Cell Harvesters
  • 8.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Biopharmaceutical Applications
    • 8.5.2. Cell Therapy
    • 8.5.3. Tissue Engineering
    • 8.5.4. Clinical Research & Trials
    • 8.5.5. Others
  • 8.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Biotech & Biopharma Companies
    • 8.6.3. Diagnostic Labs
    • 8.6.4. Academic & Research Institutes
    • 8.6.5. Others
  • 8.7. Market Attractiveness Analysis

9. East Asia Cell Harvesting System Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By End-user
  • 9.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Manual Cell Harvesters
    • 9.4.2. Automated Cell Harvesters
  • 9.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Biopharmaceutical Applications
    • 9.5.2. Cell Therapy
    • 9.5.3. Tissue Engineering
    • 9.5.4. Clinical Research & Trials
    • 9.5.5. Others
  • 9.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Biotech & Biopharma Companies
    • 9.6.3. Diagnostic Labs
    • 9.6.4. Academic & Research Institutes
    • 9.6.5. Others
  • 9.7. Market Attractiveness Analysis

10. South Asia & Oceania Cell Harvesting System Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By End-user
  • 10.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Manual Cell Harvesters
    • 10.4.2. Automated Cell Harvesters
  • 10.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Biopharmaceutical Applications
    • 10.5.2. Cell Therapy
    • 10.5.3. Tissue Engineering
    • 10.5.4. Clinical Research & Trials
    • 10.5.5. Others
  • 10.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Biotech & Biopharma Companies
    • 10.6.3. Diagnostic Labs
    • 10.6.4. Academic & Research Institutes
    • 10.6.5. Others
  • 10.7. Market Attractiveness Analysis

11. Latin America Cell Harvesting System Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By End-user
  • 11.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Manual Cell Harvesters
    • 11.4.2. Automated Cell Harvesters
  • 11.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Biopharmaceutical Applications
    • 11.5.2. Cell Therapy
    • 11.5.3. Tissue Engineering
    • 11.5.4. Clinical Research & Trials
    • 11.5.5. Others
  • 11.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Biotech & Biopharma Companies
    • 11.6.3. Diagnostic Labs
    • 11.6.4. Academic & Research Institutes
    • 11.6.5. Others
  • 11.7. Market Attractiveness Analysis

12. Middle East & Africa Cell Harvesting System Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By End-user
  • 12.3. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Manual Cell Harvesters
    • 12.4.2. Automated Cell Harvesters
  • 12.5. Market Size (US$ Bn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Biopharmaceutical Applications
    • 12.5.2. Cell Therapy
    • 12.5.3. Tissue Engineering
    • 12.5.4. Clinical Research & Trials
    • 12.5.5. Others
  • 12.6. Market Size (US$ Bn) Analysis and Forecast, By End-user, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Biotech & Biopharma Companies
    • 12.6.3. Diagnostic Labs
    • 12.6.4. Academic & Research Institutes
    • 12.6.5. Others
  • 12.7. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2024
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Esco Micro Pte. Ltd.
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Sartorius AG
    • 13.3.3. Cytiva (Danaher)
    • 13.3.4. Technical Proteins Nanobiotechnology
    • 13.3.5. Beckman Coulter, Inc
    • 13.3.6. Thermo Fisher Scientific Inc.
    • 13.3.7. Dr. Mueller AG
    • 13.3.8. Corning Incorporated
    • 13.3.9. PerkinElmer
    • 13.3.10. Revvity
    • 13.3.11. Smart MCs PTY LTD
    • 13.3.12. CARR Biosystems
    • 13.3.13. ScaleReady USA
    • 13.3.14. SINFONIA TECHNOLOGY CO., LTD
    • 13.3.15. Cole-Parmer Instrument Company, LLC
    • 13.3.16. Human Med
    • 13.3.17. ADS Biotec Inc.
    • 13.3.18. Akadeum Life Sciences
    • 13.3.19. AVITA Medical
    • 13.3.20. Tomtec

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦